← Alle mensen

JM

Jacek Mackiewicz

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow-up, crossove...

European journal of cancer (Oxford, England : 1990) · 2 mei 2025

Adjuvant pembrolizumab versus placebo bij stadium IIB/IIC melanoom: KEYNOTE-716 definitieve analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 mei 2024

QoL bij adjuvant pembrolizumab bij stadium II melanoom: KEYNOTE-716 analyse

European journal of cancer (Oxford, England : 1990) · 2022-11

Adjuvant pembrolizumab bij stadium IIB/IIC melanoom: KEYNOTE-716 tweejaars definitief

The Lancet. Oncology · 2022-11

Adjuvant pembrolizumab versus placebo bij stadium IIB/IIC melanoom: KEYNOTE-716 fase III

Lancet (London, England) · 30 april 2022